Clinical Trial Update: Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating isatuximab during stem cell collection and subsequent transplant in patients with multiple myeloma and lymphoma. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• Isatuximab (isatuximab)

Snippet

Sponsor: Divaya Bhutani | Conditions: Lymphoma, Multiple Myeloma | Phase 2 | Status: RECRUITING